Co-Diagnostics, Inc. (CODX)
USD 0.33
(2.17%)
USD 0.33
(2.17%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.63 Million USD | 105.85% |
| 2022 | 8.56 Million USD | -66.48% |
| 2021 | 25.55 Million USD | 462.89% |
| 2020 | 4.54 Million USD | 849.8% |
| 2019 | 478.07 Thousand USD | -81.7% |
| 2018 | 2.61 Million USD | 221.75% |
| 2017 | 811.8 Thousand USD | -81.08% |
| 2016 | 4.29 Million USD | 182.58% |
| 2015 | 1.51 Million USD | 1152.55% |
| 2014 | 121.21 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8.31 Million USD | -52.83% |
| 2024 Q2 | 8.3 Million USD | -0.18% |
| 2023 Q3 | 9.19 Million USD | -1.89% |
| 2023 Q1 | 6.36 Million USD | -25.67% |
| 2023 FY | 17.63 Million USD | 105.85% |
| 2023 Q2 | 9.36 Million USD | 47.14% |
| 2023 Q4 | 17.63 Million USD | 91.84% |
| 2022 Q2 | 16.37 Million USD | -30.15% |
| 2022 FY | 8.56 Million USD | -66.48% |
| 2022 Q1 | 23.43 Million USD | -8.3% |
| 2022 Q4 | 8.56 Million USD | -33.57% |
| 2022 Q3 | 12.89 Million USD | -21.22% |
| 2021 Q3 | 5.2 Million USD | -5.85% |
| 2021 FY | 25.55 Million USD | 462.89% |
| 2021 Q1 | 4.86 Million USD | 7.07% |
| 2021 Q2 | 5.52 Million USD | 13.62% |
| 2021 Q4 | 25.55 Million USD | 391.5% |
| 2020 FY | 4.54 Million USD | 849.8% |
| 2020 Q1 | 1.31 Million USD | 174.72% |
| 2020 Q2 | 3.06 Million USD | 133.34% |
| 2020 Q3 | 1.87 Million USD | -38.84% |
| 2020 Q4 | 4.54 Million USD | 142.24% |
| 2019 Q4 | 478.07 Thousand USD | 0.04% |
| 2019 FY | 478.07 Thousand USD | -81.7% |
| 2019 Q3 | 477.85 Thousand USD | -6.68% |
| 2019 Q2 | 512.07 Thousand USD | -8.15% |
| 2019 Q1 | 557.51 Thousand USD | -78.66% |
| 2018 Q2 | 726.32 Thousand USD | -4.66% |
| 2018 FY | 2.61 Million USD | 221.75% |
| 2018 Q3 | 2.58 Million USD | 256.04% |
| 2018 Q4 | 2.61 Million USD | 1.0% |
| 2018 Q1 | 761.79 Thousand USD | -6.16% |
| 2017 FY | 811.8 Thousand USD | -81.08% |
| 2017 Q4 | 811.8 Thousand USD | -5.95% |
| 2017 Q2 | 4.86 Million USD | 8.53% |
| 2017 Q1 | 4.48 Million USD | 4.43% |
| 2017 Q3 | 863.16 Thousand USD | -82.25% |
| 2016 Q3 | 2.77 Million USD | 0.0% |
| 2016 Q4 | 4.29 Million USD | 54.52% |
| 2016 FY | 4.29 Million USD | 182.58% |
| 2016 Q1 | - USD | -100.0% |
| 2015 Q4 | 1.51 Million USD | 0.0% |
| 2015 FY | 1.51 Million USD | 1152.55% |
| 2014 FY | 121.21 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 65.595% |
| BrainsWay Ltd. | 15.31 Million USD | -15.15% |
| Cerus Corporation | 144.3 Million USD | 87.78% |
| Envoy Medical, Inc. | 9.4 Million USD | -87.557% |
| electroCore, Inc. | 8.94 Million USD | -97.139% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -230.103% |
| IceCure Medical Ltd | 4.24 Million USD | -315.213% |
| Inogen, Inc. | 121.38 Million USD | 85.472% |
| OrthoPediatrics Corp. | 72.56 Million USD | 75.698% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 40.387% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -454.193% |
| MaxCyte, Inc. | 36.1 Million USD | 51.162% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -854.273% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4046.462% |
| Orthofix Medical Inc. | 326.58 Million USD | 94.6% |
| PAVmed Inc | 57.13 Million USD | 69.137% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 30.746% |
| RxSight, Inc. | 22.18 Million USD | 20.524% |
| Sight Sciences, Inc. | 46.43 Million USD | 62.025% |
| SI-BONE, Inc. | 61.05 Million USD | 71.115% |
| TELA Bio, Inc. | 59.16 Million USD | 70.196% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 84.527% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -70.89% |
| Acutus Medical, Inc. | 54.83 Million USD | 67.844% |
| Talis Biomedical Corporation | 29.22 Million USD | 39.659% |
| Spectral AI, Inc. | 12.4 Million USD | -42.199% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 23.774% |
| CVRx, Inc. | 39.28 Million USD | 55.109% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -47.466% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -625.893% |
| Bioventus Inc. | 589.79 Million USD | 97.01% |
| Venus Concept Inc. | 107.1 Million USD | 83.535% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 65.867% |
| LivaNova PLC | 1.15 Billion USD | 98.469% |
| 908 Devices Inc. | 37.49 Million USD | 52.963% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 97.493% |
| Nemaura Medical Inc. | 26.37 Million USD | 33.147% |
| NeuroPace, Inc. | 86.99 Million USD | 79.73% |
| LENSAR, Inc. | 22.4 Million USD | 21.308% |
| Apyx Medical Corporation | 52.31 Million USD | 66.294% |
| Cutera, Inc. | 518.12 Million USD | 96.597% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 39.873% |
| BioSig Technologies, Inc. | 4.68 Million USD | -276.395% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 69.788% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 17.935% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.196% |
| Axonics, Inc. | 82.35 Million USD | 78.589% |
| Outset Medical, Inc. | 190.91 Million USD | 90.763% |
| IRIDEX Corporation | 24.91 Million USD | 29.22% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 85.775% |
| IRadimed Corporation | 20.73 Million USD | 14.959% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -953.412% |
| INVO Bioscience, Inc. | 19.99 Million USD | 11.807% |
| Telesis Bio, Inc. | 40.87 Million USD | 56.856% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 56.769% |
| Varex Imaging Corporation | 668.6 Million USD | 97.363% |
| Quipt Home Medical Corp. | 136.29 Million USD | 87.062% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -393.676% |
| Pulmonx Corporation | 60.63 Million USD | 70.918% |
| Dynatronics Corporation | 11.78 Million USD | -49.694% |
| Modular Medical, Inc. | 2.27 Million USD | -676.149% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -333.91% |
| Semler Scientific, Inc. | 6.27 Million USD | -181.246% |
| InMode Ltd. | 75.91 Million USD | 76.771% |
| Bruker Corporation | 2.83 Billion USD | 99.378% |
| Cytosorbents Corporation | 29.98 Million USD | 41.191% |
| DexCom, Inc. | 4.19 Billion USD | 99.58% |
| Align Technology, Inc. | 2.45 Billion USD | 99.281% |
| Viveve Medical, Inc. | 10.84 Million USD | -62.571% |
| ZimVie Inc. | 795.85 Million USD | 97.784% |
| Movano Inc. | 5.97 Million USD | -195.28% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 83.142% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -4046.462% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -47.466% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 97.24% |
| Profound Medical Corp. | 12.66 Million USD | -39.226% |
| Insulet Corporation | 1.85 Billion USD | 99.05% |
| enVVeno Medical Corporation | 2.43 Million USD | -624.194% |
| Surmodics, Inc. | 65.82 Million USD | 73.21% |
| iCAD, Inc. | 8 Million USD | -120.399% |
| Nuwellis, Inc. | 6.78 Million USD | -160.09% |
| Biotricity, Inc. | 35.91 Million USD | 50.906% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 92.094% |
| Aethlon Medical, Inc. | 2.47 Million USD | -611.153% |
| InspireMD, Inc. | 8.14 Million USD | -116.582% |
| PAVmed Inc. | 57.13 Million USD | 69.137% |
| BIOLASE, Inc. | 35.34 Million USD | 50.113% |
| Beyond Air, Inc. | 29.77 Million USD | 40.775% |
| FONAR Corporation | 57.45 Million USD | 69.309% |
| AxoGen, Inc. | 101.16 Million USD | 82.568% |
| Vivani Medical, Inc. | 25.03 Million USD | 29.565% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 79.915% |
| Inari Medical, Inc. | 209.32 Million USD | 91.576% |
| UFP Technologies, Inc. | 118.04 Million USD | 85.062% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -38.955% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -706.754% |
| Tenon Medical, Inc. | 5.56 Million USD | -216.762% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -891.237% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.441% |
| Sintx Technologies, Inc. | 6.59 Million USD | -167.467% |
| NanoVibronix, Inc. | 2.68 Million USD | -556.52% |
| Quanterix Corporation | 78.08 Million USD | 77.416% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -393.676% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -260.985% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 98.312% |
| TransMedics Group, Inc. | 568.84 Million USD | 96.9% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -5.707% |
| NeuroMetrix, Inc. | 1.33 Million USD | -1222.766% |
| Hyperfine, Inc. | 9.8 Million USD | -79.94% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 92.953% |
| Biomerica, Inc. | 2.66 Million USD | -562.19% |
| Bone Biologics Corporation | 831.4 Thousand USD | -2021.009% |
| AVITA Medical, Inc. | 19.86 Million USD | 11.232% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -793.462% |
| Silk Road Medical, Inc | 114.15 Million USD | 84.553% |